{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:35:14Z","timestamp":1787668514015,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Pediatric and Adolescent Health Care"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cppeds.2025.101886","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T20:32:34Z","timestamp":1764448354000},"page":"101886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurofibromatosis review with focus on rehabilitation intervention"],"prefix":"10.1016","volume":"55","author":[{"given":"Mi Ran","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Turnacioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cppeds.2025.101886_bib0001","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cppeds.2025.101886_bib0002","volume":"9","author":"Bergoug","year":"2020","journal-title":"Neurofibromin Struct Funct Regul Cells"},{"key":"10.1016\/j.cppeds.2025.101886_bib0003","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.18632\/oncotarget.2194","article-title":"The NF1 gene revisited - from bench to bedside","volume":"5","author":"Yap","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.cppeds.2025.101886_bib0004","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.26.11.704","article-title":"A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity","volume":"26","author":"Huson","year":"1989","journal-title":"J Med Genet"},{"key":"10.1016\/j.cppeds.2025.101886_bib0005","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cppeds.2025.101886_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.c.32095","article-title":"Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome","volume":"196","author":"Garzon","year":"2024","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.cppeds.2025.101886_bib0007","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.cppeds.2025.101886_bib0008","article-title":"Council on genetics, & American college of medical genetics and genomics","volume":"143","author":"Miller","year":"2019","journal-title":"Health Superv Child Neurofibromat type 1.,Pediatric"},{"issue":"7","key":"10.1016\/j.cppeds.2025.101886_bib0009","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101886_bib0010","first-page":"31","article-title":"Treatment of ADHD in neurofibromatosis type 1","volume":"61","author":"Mautner","year":"2019","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101886_bib0011","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PEP.0b013e3181f9dbc8","article-title":"Motor proficiency in children with neurofibromatosis type 1","volume":"22","author":"Johnson","year":"2010","journal-title":"Pediatr Phys Ther"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101886_bib0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.b.32280","article-title":"Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1","volume":"168B","author":"Plasschaert","year":"2015","journal-title":"Am J Med Genet B Neuropsychiatr Genet: Off Publ Int Soc Psychiatr Genet"},{"issue":"8","key":"10.1016\/j.cppeds.2025.101886_bib0013","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/children11081033","article-title":"Quality of life in children with neurofibromatosis type 1: agreement between parents and patients, and the role of disease severity and visibility","volume":"11","author":"Cavallo","year":"2024","journal-title":"Children"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101886_bib0014","first-page":"15","article-title":"Muscular force is reduced in neurofibromatosis type 1","volume":"9","author":"Souza","year":"2009","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"2","key":"10.1016\/j.cppeds.2025.101886_bib0015","first-page":"161","article-title":"Skeletal muscle and motor deficits in neurofibromatosis type 1","volume":"15","author":"Summers","year":"2015","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"5","key":"10.1016\/j.cppeds.2025.101886_bib0016","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/dmcn.12361","article-title":"Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1","volume":"56","author":"Champion","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"19","key":"10.1016\/j.cppeds.2025.101886_bib0017","article-title":"Motor problems in children with neurofibromatosis type 1","volume":"9","author":"Rietman","year":"2017","journal-title":"J Neurodev Disord"},{"issue":"8","key":"10.1016\/j.cppeds.2025.101886_bib0018","first-page":"1357","article-title":"Clinical evaluation of muscle functions in neurofibromatosis type 1","volume":"58","author":"Gurler","year":"2022","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"10.1016\/j.cppeds.2025.101886_bib0019","first-page":"145","article-title":"Case-control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography","volume":"5","author":"Stevenson","year":"2005","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"8","key":"10.1016\/j.cppeds.2025.101886_bib0020","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth","volume":"16","author":"Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.cppeds.2025.101886_bib0021","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.3390\/jcm13113311","article-title":"Magnetic resonance imaging of Central nervous system manifestations of type 1 neurofibromatosis: pictorial review and retrospective study of their frequency in a cohort of patients","volume":"13","author":"Di Pietro","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101886_bib0022","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13760-023-02381-0","article-title":"The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis","volume":"124","author":"Di Stasi","year":"2024","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101886_bib0023","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.humov.2011.05.004","article-title":"Lower extremity strength and hopping and jumping ground reaction forces in children with neurofibromatosis type 1","volume":"31","author":"Johnson","year":"2012","journal-title":"Hum Mov Sci"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101886_bib0024","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ridd.2010.03.005","article-title":"Participation and handwriting performance of children with neurofibromatosis type 1","volume":"31","author":"Gilboa","year":"2010","journal-title":"Res Dev Disabil"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101886_bib0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1469-8749.1995.tb12026.x","article-title":"Cognitive function and academic performance in children with neurofibromatosis type 1","volume":"37","author":"North","year":"1995","journal-title":"Dev Med Child Neurol"},{"issue":"10","key":"10.1016\/j.cppeds.2025.101886_bib0026","first-page":"1327","article-title":"Developmental delays in children with neurofibromatosis type 1","volume":"27","author":"Soucy","year":"2012","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.cppeds.2025.101886_bib0027","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1469-8749.2012.04399.x","article-title":"Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence","volume":"55","author":"Lehtonen","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"10.1016\/j.cppeds.2025.101886_bib0028","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/dmcn.13526","article-title":"Neurodevelopmental disorders in children with neurofibromatosis type 1","volume":"59","author":"Vogel","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101886_bib0029","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/cancers15041217","article-title":"Neurofibromatosis type 1: pediatric aspects and review of genotype\u2013phenotype correlations","volume":"15","author":"Peduto","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101886_bib0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaac.2024.09.011","article-title":"Systematic review and meta-analysis: attention-deficit\/hyperactivity disorder symptoms in children with neurofibromatosis type 1","volume":"64","author":"Hou","year":"2025","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.cppeds.2025.101886_bib0031","article-title":"Attention-deficit\/hyperactivity disorder in children ages 5\u201317 years: united States, 2020\u20132022","volume":"499","author":"Reuben","year":"2024","journal-title":"NCHS Data Br"},{"issue":"9","key":"10.1016\/j.cppeds.2025.101886_bib0032","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1469-8749.2012.04377.x","article-title":"The adverse influence of attention deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1","volume":"54","author":"Lidzba","year":"2012","journal-title":"Dev Med Child Neurol"},{"issue":"1\u20134","key":"10.1016\/j.cppeds.2025.101886_bib0033","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s40817-015-0007-3","article-title":"The relation between ADHD and cognitive profiles of children with NF1","volume":"1","author":"Potvin","year":"2015","journal-title":"J Pediatr Neuropsychol"},{"issue":"9","key":"10.1016\/j.cppeds.2025.101886_bib0034","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00381-020-04745-w","article-title":"An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains","volume":"36","author":"Smith","year":"2020","journal-title":"Child 19s Nerv Syst"},{"issue":"2","key":"10.1016\/j.cppeds.2025.101886_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/dmcn.12043","article-title":"Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study","volume":"55","author":"Garg","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.cppeds.2025.101886_bib0036","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/dmcn.12038","article-title":"Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1","volume":"55","author":"Walsh","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.cppeds.2025.101886_bib0037","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13229-021-00481-3","article-title":"Delineating the autistic phenotype in children with neurofibromatosis type 1","volume":"13","author":"Chisholm","year":"2022","journal-title":"Mol Autism"},{"issue":"10","key":"10.1016\/j.cppeds.2025.101886_bib0038","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1007\/s10803-016-2877-3","article-title":"Brief report: the prevalence of neurofibromatosis type 1 among children with autism spectrum disorder identified by the Autism and Developmental Disabilities Monitoring Network","volume":"46","author":"Bilder","year":"2016","journal-title":"J Autism Dev Disord"},{"issue":"7","key":"10.1016\/j.cppeds.2025.101886_bib0039","first-page":"750","article-title":"Congenital pseudarthrosis of the tibia","volume":"97","author":"Pannier","year":"2011","journal-title":"Orthop Traumatol: Surg Res"},{"issue":"Suppl 1","key":"10.1016\/j.cppeds.2025.101886_bib0040","article-title":"The silent thief: neurofibromatosis type 1 leading to severe osteoporosis and recurrent bone fractures","volume":"8","author":"Sacoto","year":"2024","journal-title":"J Endocr Soc"},{"issue":"7","key":"10.1016\/j.cppeds.2025.101886_bib0041","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/healthcare9070881","article-title":"Natural history of scoliosis in children with NF1: an observation study","volume":"9","author":"Toro","year":"2021","journal-title":"Healthcare"},{"issue":"6","key":"10.1016\/j.cppeds.2025.101886_bib0042","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5435\/00124635-201006000-00007","article-title":"Orthopaedic manifestations of neurofibromatosis type 1","volume":"18","author":"Feldman","year":"2010","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.cppeds.2025.101886_bib0043","first-page":"85","article-title":"Neurofibromatosis 1 French national guidelines based on an extensive literature review and expert consensus","volume":"15","author":"Bergqvist","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101886_bib0044","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2011.04.008","article-title":"Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits","volume":"159","author":"Nguyen","year":"2011","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.cppeds.2025.101886_bib0045","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/ajmg.a.37123","article-title":"Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life","volume":"167A","author":"Wolters","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"8","key":"10.1016\/j.cppeds.2025.101886_bib0046","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00381-022-05513-8","article-title":"Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA","volume":"38","author":"Yang","year":"2022","journal-title":"Child 19s Nerv Syst"},{"issue":"5","key":"10.1016\/j.cppeds.2025.101886_bib0047","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/j.pain.0000000000001486","article-title":"Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment","volume":"160","author":"Bellampalli","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.cppeds.2025.101886_bib0048","article-title":"Neurofibromatosis type 1 - an update","volume":"52","author":"Moodley","year":"2024","journal-title":"Semin Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.cppeds.2025.101886_bib0049","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1152\/jn.00489.2005","article-title":"Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability","volume":"94","author":"Wang","year":"2005","journal-title":"J Neurophysiol"},{"issue":"15","key":"10.1016\/j.cppeds.2025.101886_bib0050","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.cppeds.2025.101886_bib0051","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","article-title":"Optic pathway gliomas in neurofibromatosis type 1: an update","volume":"37","author":"de Blank","year":"2017","journal-title":"J Neuro-Ophthalmol"},{"issue":"3","key":"10.1016\/j.cppeds.2025.101886_bib0052","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101886_bib0053","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MPH.0000000000002060","article-title":"Vision outcomes for pediatric patients with optic pathway gliomas associated with neurofibromatosis type I: a systematic review of the clinical evidence","volume":"43","author":"Thirunavu","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"10","key":"10.1016\/j.cppeds.2025.101886_bib0054","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/neuonc\/noad086","article-title":"Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1\/2 trial for inoperable plexiform neurofibromas","volume":"25","author":"Gross","year":"2023","journal-title":"Neuro-oncol"},{"key":"10.1016\/j.cppeds.2025.101886_bib0055","series-title":"Protecting Students With disabilities: Frequently asked Questions About Section 504 and the Education of Children With Disabilities","author":"Department of Education","year":"2020"},{"key":"10.1016\/j.cppeds.2025.101886_bib0056","series-title":"A Guide to the Individualized Education Program","year":"2008"}],"container-title":["Current Problems in Pediatric and Adolescent Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544225001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544225001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:35:12Z","timestamp":1765370112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538544225001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1538544225001609"],"URL":"https:\/\/doi.org\/10.1016\/j.cppeds.2025.101886","relation":{},"ISSN":["1538-5442"],"issn-type":[{"value":"1538-5442","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis review with focus on rehabilitation intervention","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Pediatric and Adolescent Health Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cppeds.2025.101886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101886"}}